CoChat

The macrophage activation marker sCD 163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease

Open access
Kazankov, Konstantin, Barrera, Francisco, Møller, Holger Jon, Rosso, Chiara, Bugianesi, Elisabetta, David, Ezio, Ibrahim Kamal Jouness, Ramy, Esmaili, Saeed, Eslam, Mohammed, McLeod, Duncan, Bibby, Bo Martin, Vilstrup, Hendrik, George, Jacob, Grønbæk, Henning · 2016 · Liver International
Cited by 113

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background & Aims: Macrophage activation plays a key pathogenic role in experimental non‐alcoholic fatty liver disease (NAFLD) and contributes to the progression of steatohepatitis (NASH) and fibrosis. We studied macrophage activation in human NAFLD by measuring soluble (s)CD 163, a specific macrophage activation marker, hypothesizing that sCD 163 would be associated with the patients’ morphological disease grade. Furthermore, we investigated an association between sCD 163 and the apoptosis marker cytokeratin‐18 (CK‐18) to explore a link between macrophage activation and apoptosis. Methods: sCD 163 associations with biochemical and histological measures of NAFLD were investigated in two independent cohorts of 157 Australian and 174 Italian NAFLD patients, with liver biopsies graded for NAFLD severity, steatosis and fibrosis. sCD 163 and CK‐18 were measured by enzyme‐linked immunosorbent assay. Results: In both cohorts sCD 163 increased in parallel with the patients’ morphological disease grading, being independently associated with the Kleiner fibrosis score (P < 0.001). A high sCD 163 predicted advanced fibrosis {F ≥ 3; Australian cohort: area under receiver‐operating characteristics curve 0.77 [95% confidence interval (CI): 0.76–0.87], Italian cohort: 0.80 (95% CI: 0.72–0.88)}. In both groups, sCD 163 was independently associated with CK‐18 (P < 0.001). Conclusion: Soluble CD 163 reflecting macrophage activation is associated with morphological features of NAFLD suggesting their involvement in the pathogenesis of NAFLD, NASH and particularly fibrosis. An independent association between sCD 163 and cytokeratin‐18 suggests that apoptosis may contribute to macrophage activation in NAFLD/NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.13150

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 113

Metadata

Authors
Kazankov, K., Barrera, F., Møller, H. J., Rosso, C., Bugianesi, E., David, E., Ibrahim Kamal Jouness, R., Esmaili, S., Eslam, M., McLeod, D., Bibby, B. M., Vilstrup, H., George, J., & Grønbæk, H.
Venue
Liver International
Publisher
Wiley
Published
2016-05-12
Volume
36
Issue
10
Pages
1549-1557
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2337435850
Cited by
113
References
9
FWCI
10.09
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.